Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT04183556
Eligibility Criteria:
Inclusion Criteria:
1. Early-onset primary dysmenorrhea (Definition: Pain that begins in less than 6 months, is not accompanied by infection, begins on the first day of menstruation and ends on the last day of menstruation)
2. Non-pregnant and breastfeeding patients
3. Between 16-35 years old
4. No anatomic pathology or disease
5. Lack of active infection
6. No history of drug use
7. BMI is less than 25
8. Those who wish to participate in the study signed the consent form
9. Smoking, non-alcoholic patients
10. Patients who completed their treatment and came to the control
11. Regular menstruation
Exclusion Criteria:
1. Presence of vaginal infection such as Trichomonas vaginalis and candida albicans
2. Patients who do not want to participate in the study
3. Pregnant and nursing patients
4. Be under 16 years or older than 30 years
5. Systemic disease
6. Smoking, alcohol consumption
7. BMI higher than 25
8. People with organic pelvic pathology (ovarian cyst, fibroids, polyps)
9. People with a history of drug use
10. Patients who discontinue treatment and do not come to control
11. Irregular menstruation
12. Any history of contraindication to naproxen
13. Turmeric allergy history
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
16 Years
Maximum Age:
35 Years
Study:
NCT04183556
Study Brief:
Protocol Section:
NCT04183556